Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Ophthalmologic Medicine(Electronic Edition) ›› 2023, Vol. 13 ›› Issue (04): 193-198. doi: 10.3877/cma.j.issn.2095-2007.2023.04.001

• Editorial •     Next Articles

Pay attention to the pathogenesis and prevention and control measures of posterior cataract

Xiuli Sun, Zhenyu Liu, Tingting Tang, Jingshang Zhang, Meng Li, Yingyan Mao, Xiuhua Wan()   

  1. Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab., Beijing 100730, China
  • Received:2023-05-03 Online:2023-08-28 Published:2023-11-21
  • Contact: Xiuhua Wan

Abstract:

Posterior cataract (PCO) is the main complication after extracapsular cataract extraction and phacoemulsification. It has demonstrated that residual lens epithelial cell epithelial mesenchymal transition (EMT) after surgery is the main cause of PCO formation, and its pathogenesis involves the involvement of numerous signaling pathways, cytokines, growth factors, proteases, and integrins. The existing methods for preventing and controlling PCO include laser therapy, drug therapy, modification of intraocular lens (IOL) materials, and gene therapy. The current pathogenesis and prevention and control measures of posterior cataract were reviewed in this paper.

Key words: Posterior capsule opacification, Epithelial-to-mesenchymal transition, Drugs, Nanophase materials, Gene therapy

Copyright © Chinese Journal of Ophthalmologic Medicine(Electronic Edition), All Rights Reserved.
Tel: 0086-10-58269646 E-mail: zhykyxzz@163.com
Powered by Beijing Magtech Co. Ltd